![QT Imaging and, my alma mater, the University of Illinois Urbana-Champaign Partner on $3.1 Million NCI Research Grant for Breast Cancer Treatment Monitoring – Christopher Clinton Conway](https://oncodaily.com/pub/uploads/2023/07/Christopher-1280x1180.jpeg)
QT Imaging and, my alma mater, the University of Illinois Urbana-Champaign Partner on $3.1 Million NCI Research Grant for Breast Cancer Treatment Monitoring – Christopher Clinton Conway
QT Imaging and, my alma mater, the University of Illinois Urbana-Champaign Partner on $3.1 Million National Cancer Institute (NCI) Research Grant for Breast Cancer Treatment Monitoring 🧡💙
The grant will use QT Imaging’s Breast Scanning System enhanced with reflection back-scatter algorithms developed by the University of Illinois to assess tumor response to treatment in days rather than weeks or months.
“Currently, if a breast cancer patient does not respond to the initial chemotherapy regimen, there may be little recourse for adjusting the therapy regimen to the benefit of the patient because the lack of response is not identified early on during the course of therapy. By identifying response or lack of response early on during the course of therapy, physicians will be able to adjust therapy approaches and thereby improve outcomes,” said Dr. Michael Oelze, University of Illinois Urbana-Champaign.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023